Prof. Jun Nakajima: to keep aggressive and innovative in the field of thoracic surgery
Editor’s note
The First Shanghai Chest Hospital Forum on International Medical Robot Minimally Invasive Surgery was held in Shanghai during March 21–23, 2019.
It has invited many world-renowned experts in the field of robotic and thoracoscopic surgery both at home and abroad, with the purpose to further study the nature of medical robotic surgery, and to explore the application of AI in thoracic surgery.
Prof. Jun Nakajima, from the University of Tokyo Hospital, made a speech to share the experience on thoracic surgery in his hospital (Figure 1). With a great honor, Shanghai Chest has a chance to interview with Prof. Jun Nakajima during the meeting (Figure 2).
Recently number of patients with lung cancer has been increasing in the world, especially in East Asian countries. Needs for less-invasive thoracic surgeries are also increasing because patients with lung cancer are generally older and they frequently have comorbidities associated with tobacco smoking. Lung transplantation has become a standard treatment for patients with diffuse lung diseases that cannot be cured by medication. For these diseases, further technological and biological innovation is necessary to improve outcome of treatment.
Expert’s introduction
Dr. Jun Nakajima is a vice-director of The University of Tokyo Hospital, and Professor of Thoracic Surgery, The University of Tokyo Graduate School of Medicine in Tokyo Japan. He is also the chief of the Department of Thoracic Surgery of the University of Tokyo Hospital. Dr. Nakajima earned his MD from The University of Tokyo in 1982, and PhD from The University of Tokyo Graduate School of Medicine in 1992, and he became a certified thoracic surgeon in Japan after residency of The University of Tokyo Hospital and other associate hospitals. Dr. Nakajima has performed thoracoscopic surgery since 1993, and he published many articles on clinical studies of thoracoscopic surgeries for thoracic malignant diseases. After he became the chief of the thoracic surgery in The University of Tokyo Hospital, He established lung transplantation program, and he and his colleagues performed the first lung transplantation in Tokyo in 2015. He is an executive council of Asian Society for Cardiovascular and Thoracic Surgery (ASCVTS), and he is working as a member of American Association for Thoracic Surgery (AATS) and European Association for Cardiothoracic Surgery (EACTS).
Interview
Acknowledgments
Funding: None.
Footnote
Provenance and Peer Review: This article was commissioned by the Editorial Office, Shanghai Chest. The article did not undergo external peer review
Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/shc.2019.04.03). The authors have no conflicts of interest to declare.
Ethical Statement: The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.
References
- Liu X, Wang MJ. Prof. Jun Nakajima: to keep aggressive and innovative in the field of thoracic surgery. Asvide 2019;6:122. Available online: http://www.asvide.com/article/view/31317
(Science Editors: Xing Liu, Molly J. Wang, SHC, shc@amegrouops.com)
Cite this article as: Liu X, Wang MJ. Prof. Jun Nakajima: to keep aggressive and innovative in the field of thoracic surgery. Shanghai Chest 2019;3:26.